The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Evaluation of monocytic myeloid-derived suppressor cell (M-MDSC) frequency in patients with metastatic urothelial carcinoma (mUC).
 
Samuel Funt
Stock and Other Ownership Interests - Kite, a Gilead company
 
Zhenyu Mu
No Relationships to Disclose
 
Catharine Kline Cipolla
No Relationships to Disclose
 
Brooke Elizabeth Kania
No Relationships to Disclose
 
Junting Zheng
No Relationships to Disclose
 
Mariel Elena Boyd
No Relationships to Disclose
 
Alexandra Snyder Charen
Honoraria - Bristol-Myers Squibb; Merck; Syndax
Consulting or Advisory Role - Third Rock Ventures
 
Margaret K. Callahan
Employment - Bristol-Myers Squibb (I); Celgene (I)
Consulting or Advisory Role - AstraZeneca
Research Funding - Bristol-Myers Squibb (Inst)
 
Karen A. Autio
No Relationships to Disclose
 
Ashley Marie Regazzi
No Relationships to Disclose
 
Meredith Maisie Moran
No Relationships to Disclose
 
Irina Ostrovnaya
No Relationships to Disclose
 
Gopa Iyer
No Relationships to Disclose
 
Phillip Wong
Consulting or Advisory Role - Merck
Patents, Royalties, Other Intellectual Property - Receive small annual royalty payments from the University of Washington for a monoclonal antibody that was developed during my graduate studies there.
 
Alexander M. Lesokhin
Honoraria - Bristol-Myers Squibb; Gilead Sciences (I); Janssen Oncology; Novartis
Consulting or Advisory Role - Bristol-Myers Squibb; Foundation Medicine (Inst); Janssen Oncology; Novartis
Research Funding - Bristol-Myers Squibb (Inst); Janssen Oncology (Inst)
Patents, Royalties, Other Intellectual Property - Serametrix, Inc
 
Jonathan E. Rosenberg
Stock and Other Ownership Interests - Illumina; Merck
Honoraria - UpToDate
Consulting or Advisory Role - Boehringer Ingelheim; Bristol-Myers Squibb; Dendreon; Janssen Oncology; Johnson & Johnson; Lilly; Merck; Oncogenex; Onyx
Research Funding - Agensys; Genentech; Mirati Therapeutics; Oncogenex
Patents, Royalties, Other Intellectual Property - ERCC2 predicting cisplatin sensitivity
Travel, Accommodations, Expenses - Genentech/Roche
 
Dean F. Bajorin
Honoraria - Merck Sharp & Dohme
Consulting or Advisory Role - Bristol-Myers Squibb; Eisai; Fidia Farmaceutici S. p. A.; Genentech; Lilly; Lilly; Merck; Novartis; Roche; Roche/Genentech; Urogen pharma
Research Funding - Amgen (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); dendreon (Inst); Genentech/Roche (Inst); Merck (Inst); Novartis (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Lilly; Merck; Roche/Genentech